# United States Commodity Index Funds Trust: overview USCI · NYSE · CIK 1479247 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/usci.md) · [Financials](/companies/usci/financials.md) · [Filings](/companies/usci/filings.md) · [Insiders](/companies/usci/insiders.md) Latest reported revenue: [−$54.7m](/filings/0001104659-20-058625.md) for Q1 FY2020, three months to 2020-03-31, from the 10-Q filed May 8, 2020 (XBRL us-gaap:Revenues, accession 0001104659-20-058625). ## Last eight quarters | Line item | Unit | Q2 FY2020 (2020-06-30) | Q3 FY2020 (2020-09-30) | Q4 FY2020 (2020-12-31) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q4 FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2017 (2017-12-31) | FY (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [34.1](/filings/0001104659-20-032921.md) | [(68.9)](/filings/0001104659-21-029196.md) | [(4.2)](/filings/0001104659-21-029196.md) | [(16.6)](/filings/0001104659-21-029196.md) | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [84.0%](/filings/0001104659-20-032921.md) | [108.8%](/filings/0001104659-21-029196.md) | [192.0%](/filings/0001410578-22-000220.md) | [109.6%](/filings/0001410578-22-000220.md) | not reported | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/usci/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $46.3m | 1,227,457 | | Reduced −223,852 | | [MATAURO, LLC](/funds/2052964.md) | 2026-06-30 | $33.8m | 364,568 | | Added +18,884 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $23.3m | 618,500 | Call | Reduced −413,500 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $22.5m | 595,500 | Call | Added +418,900 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $16.8m | 443,952 | | Added +28,735 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $15.3m | 164,771 | | Added +15,968 | | [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $13.7m | 148,283 | | Reduced −253 | | [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $12.7m | 337,449 | | Added +178,237 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $10.8m | 286,700 | Call | Reduced −29,500 | | [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $10.1m | 268,100 | Put | Added +151,400 | ## Recent filings [All 716 filings](/companies/usci/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-30 | 11:27 ET | [8-K](/filings/0001104659-26-120528.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-120528 | | 2026-09-29 | 12:41 ET | [8-K](/filings/0001104659-26-111783.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-111783 | | 2026-09-25 | 17:29 ET | [8-K](/filings/0002071876-26-000223.md) | 1.01 Entry into a material agreement | 0002071876-26-000223 | | 2026-08-28 | 08:27 ET | [8-K](/filings/0001104659-26-102792.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-102792 | | 2026-08-07 | 15:06 ET | [10-Q](/filings/0001104659-26-092635.md) | Quarterly report, period 2026-06-30 | 0001104659-26-092635 | | 2026-07-29 | 08:36 ET | [8-K](/filings/0001104659-26-087863.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-087863 | | 2026-06-29 | 08:22 ET | [8-K](/filings/0001104659-26-078529.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-078529 | | 2026-05-28 | 08:31 ET | [8-K](/filings/0001104659-26-067268.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-067268 | | 2026-05-08 | 14:12 ET | [10-Q](/filings/0001104659-26-057792.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057792 | | 2026-04-29 | 08:31 ET | [8-K](/filings/0001104659-26-050940.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-050940 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-021525.md), filed Feb 27, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1479247 - Tickers: USCI, CPER - Exchange: NYSE - SIC code: 6221 Commodity Contracts Brokers & Dealers - State of incorporation: not reported - Filer category: Accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 11:29 ET. No prices; not investment advice.